Cleared Traditional

K902362 - COAGULATION CONTROL

K902362 is the FDA 510(k) clearance for COAGULATION CONTROL by Sigma Chemical Co.. It is a Class 2 Hematology device (product code GGN) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K902362 · Sigma Chemical Co. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1990
Decision
58d
Days
Class 2
Risk

K902362 is an FDA 510(k) clearance for the COAGULATION CONTROL, LEVEL II. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by Sigma Chemical Co. (St. Louis, US). The FDA issued a Cleared decision on July 26, 1990 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sigma Chemical Co. devices

Submission Details

510(k) Number K902362 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 1990
Decision Date July 26, 1990
Days to Decision 58 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 113d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 55
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K902362.
ROCKET REFERENCE PLASMA, CAT. NO. 5188, MODIFIED
K911777 · Helena Laboratories · Aug 1991
AB-TROL II COAGULATION CONTROL PLASM CAT. NO. 5183
K905673 · Helena Laboratories · Feb 1991
COAGULATION CONTROL, LEVEL I
K902361 · Sigma Chemical Co. · Jul 1990
COAGULATION CONTROL, LEVEL III
K902363 · Sigma Chemical Co. · Jul 1990
ORTHOKROME NORMAL AND ABNORMAL CONTROL PLASMA
K902210 · Ortho Diagnostic Systems, Inc. · Jul 1990
ROCKET REFERENCE PLASMA, CAT NO. 5188
K900019 · Helena Laboratories · Jan 1990